Glycologix LLC is an emerging glycobiologics company structured around development of novel biomimetic proteoglycan materials that offer the potential of enabling ground-breaking therapeutic solutions to the repair of dermis, cartilage and other connective tissues damaged by disease and aging. The firm is targeting locally delivered biopolymers for the protection/ repair of soft tissues. With there being multiple unmet medical conditions that can be addressed by replenishment of naturally occurring proteoglycans, the firm's platform discovery engine enables the preparation of synthetic structural mimics of proteoglycans. Despite their high molecular weight, these novel materials are are highly soluble, enabling optimal tissue coverage. Focused indications for the platform include interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair
